Region: Brazil

Brazil: Navigating patenting challenges in the pharmaceutical landscape

Featured in The Guide to Life Sciences: Key issues for senior life sciences executives 2024

Brazil is a strategic market for many local and foreign pharmaceutical companies due to its protective legislation with regard to access to healthcare. However, its pharma ecosystem is complex and requires a comprehensive understanding of the legal framework that governs IP protection.

24 June 2024

The top Chinese patent holders adding Brazil to their strategic maps

Huawei and pharma giant Hengrui Pharmaceuticals are among the top patent filers in Latin America’s hottest IP jurisdiction

30 May 2024

Pharma patents to be hit hardest by changes to prosecution appeal rules in Brazil

It is also unclear whether thousands of pending challenges will be affected by the process change

26 April 2024

Brazil Supreme Court affirms term adjustment of non-pharmaceutical Monsanto patent

The decision hands an agribusiness asset case back to the trial court with potentially heavy financial ramifications for the IP owner and parent company Bayer

17 April 2024

Brazilian court hands down first tech permanent injunction to Netflix, as SEP litigation continues to rise

Featured in SEP/FRAND Hub 2023/2024

DivX, Ericsson, Dolby and Nokia are among the successful patent holders that have won preliminary injunctions in 2023. Brazil’s critical position in the tech market, as well as the willingness of courts to grant injunctions are cementing the country’s status as a key litigation venue.

14 March 2024